Pivotal bioVenture Partners (China) is based in Shanghai and aims to bring first-in-class products and technologies to the Chinese market.

Oncologie is developing next-generation biologics and small molecules. Oncologie’s portfolio covers the spectrum of the cancer immunology landscape. Our teams in Boston and Shanghai are working together to bring new therapies to patients.

Based in Shanghai, China, Arctic Vision Limited is a biotech company focusing on the development of innovative ophthalmic pharmaceuticals, biologicals and medical devices. We target on breakthrough therapies and technologies with potential to revolutionize the eye care conventions, and bring cure to the incurable to address sight-threatening diseases with high unmet needs.